Kronox Lab Sciences Reports Strong FY26 Performance and Expansion Plans

Kronox Lab Sciences has announced its financial results for the fiscal year 2026, with net profit rising by 8.61% to Rs 27.66 crore. The company also proposed a final dividend of Rs 0.50 per equity share.

Reader Takeaway: Steady profit growth and a proposed dividend are positives; Dahej expansion execution is key.

What just happened

Kronox Lab Sciences reported a total income of Rs 106.41 crore for FY26, a slight increase from Rs 102.72 crore in FY25. Net profit after tax (PAT) grew to Rs 27.66 crore from Rs 25.47 crore in the previous year. The operating EBITDA margin saw a marginal improvement to 33.86% from 33.06%.

Why this matters

The company's consistent profit growth and proposed dividend offer a direct return to shareholders. The planned expansion at Dahej, despite some delays, signals future capacity enhancement, which is crucial for sustained growth in the pharmaceutical ingredients sector.

The backstory

Kronox Lab Sciences operates three manufacturing units in Vadodara, Gujarat, holding certifications like FSSC 22000, ISO 9001, ISO 14001, and ISO 45001. The company has acquired land for Unit IV at GIDC, Dahej, for expansion.

What changes now

The company plans to commence construction for its Unit IV at Dahej shortly. While production is expected to begin within two years, full functionality is anticipated in three years. This expansion is aimed at increasing manufacturing capacity.

Risks to watch

Delays in the commencement and completion of the Dahej Unit IV project, as alluded to by 'unforeseen circumstances', could impact future growth projections. Execution risks associated with large-scale construction projects also remain a factor.

Peer comparison

Information on specific peers for Kronox Lab Sciences's niche in pharmaceutical ingredients is not directly provided in the filing. However, companies in the broader specialty chemicals and pharmaceutical intermediates sector typically focus on capacity expansion, R&D, and regulatory compliance.

Context metrics (time-bound)

For FY26, Revenue from Operations stood at Rs 101.22 crore, Total Income at Rs 106.41 crore, and Net Profit at Rs 27.66 crore. The basic Earnings Per Share (EPS) was Rs 7.51. The operating EBITDA margin was 33.86%.

What to track next

Investors should closely monitor the progress of the Dahej Unit IV construction and seek updates in future quarterly filings. Any further details on the timeline for commencement of operations and capacity enhancements will be critical.